Autism Clinical Trials

A listing of Autism medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study evaluating NNZ-2566 and Placebo for the treatment of Rett Syndrome

Dothan Alabama 36303

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Arizona

SARRC
Phoenix Arizona 85006

A Double-Blind, Randomized, Placebo Controlled Study of CM-AT for the Treatment of Autism in Children 3-8 Years Old.

Univ. of Arizona MC
Tucson Arizona 85724-5073

A Double-Blind, Randomized, Placebo Controlled Study of CM_AT for the Treatment of Autism in Children 3-8 Years Old.

View More ▼

UPDATED

Phoenix Arizona

A Phase 0 clinical study for patients with Autism Spectrum Disorder

Phoenix Arizona 85006

A clinical research study of CM-AT and Placebo for the treatment of Autism

Phoenix Arizona 85006

A clinical research study of CM-AT for the treatment of Autism

Phoenix Arizona 85006

A clinical research study of RG7314 and Placebo for the treatment of Autistic Disorder

Scottsdale Arizona 85254

Patients are needed to participate in a clinical research study to evaluate Autism Spectrum Disorder or Developmental Disorder

Tucson Arizona 85724

A clinical research study of CM-AT and Placebo for the treatment of Autism

Tucson Arizona 85724

A clinical research study of CM-AT for the treatment of Autism

Arkansas

UAMS College of Med., (Ark)
Little Rock Arkansas 72202

A Double-Blind, Randomized, Placebo Controlled Study of CM-AT for the Treatment of Autism in Children 3-8 Years Old.

View More ▼

Little Rock Arkansas 72202

A clinical study for patients using Ampicillin

Little Rock Arkansas 72202

A clinical research study of CM-AT and Placebo for the treatment of Autism

Little Rock Arkansas 72202

A clinical research study of CM-AT for the treatment of Autism

Little Rock Arkansas 72202

Patients are needed to participate in a clinical research study to evaluate Autism Spectrum Disorder or Developmental Disorder

California

NRC Reseach Institute
Orange California 92868

A Double-Blind, Randomized, Placebo Controlled Study of CM-AT for the Treatment of Autism in Children 3-8 Years Old.

MIND Inst., (UC, Davis)
Sacramento California 95817

A Double-Blind, Randomized, Placebo Controlled Study of CM-AT for the Treatment of Autism in Children 3-8 Years Old.

UCSF
San Francisco California 94143

A Double-Blind, Randomized, Placebo Controlled Study of CM-AT for the Treatment of Autism in Children 3-8 Years Old.

View More ▼

UPDATED

San Francisco California

A Phase 0 clinical study for patients with Autism Spectrum Disorder

Culver City California 90230

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Downey California 90241

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Garden Grove California 92845

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

La Jolla California 92093

A clinical study for patients using Ampicillin

Los Angeles California 90095

A clinical study for patients using Ampicillin

Orange California 92868

A clinical research study of CM-AT and Placebo for the treatment of Autism

Orange California 92868

A clinical research study of CM-AT for the treatment of Autism

Sacramento California 95817

A clinical research study of CM-AT and Placebo for the treatment of Autism

Sacramento California 95817

Patients are needed to participate in a clinical research study to evaluate Autism Spectrum Disorder or Developmental Disorder

San Diego California 92108

A clinical research study of RG7314 and Placebo for the treatment of Autistic Disorder

San Francisco California 94143-0984

A clinical research study of CM-AT and Placebo for the treatment of Autism

San Francisco California 94143-0984

A clinical research study of CM-AT for the treatment of Autism

San Francisco California 94143

A clinical research study of RG7314 and Placebo for the treatment of Autistic Disorder

Santa Ana California 92701

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Colorado

NEW

IMMUNOe Research Centers
Centennial Colorado 80112

A Double-Blind, Randomized, Placebo Controlled Study of CM-AT for the Treatment of Autism in Children 3-8 Years Old.

View More ▼

Aurora Colorado 80045

A clinical study for patients using Ampicillin

Centennial Colorado 80112

A clinical research study of RG7314 and Placebo for the treatment of Autistic Disorder

Connecticut

Yale Univ.,School of Medicine
New Haven Connecticut 6519

A Double-Blind, Randomized, Placebo Controlled Study of CM-AT for the Treatment of Autism in Children 3-8 Years Old.

View More ▼

UPDATED

New Haven Connecticut

A Phase 0 clinical study for patients with Autism Spectrum Disorder

New Haven Connecticut 06504

A clinical study for patients using Ampicillin

New Haven Connecticut 06510

A clinical research study of RG7314 and Placebo for the treatment of Autistic Disorder

Delaware

Wilmington Delaware 19803

A clinical study for patients using Ampicillin

District of Columbia

Washington District of Columbia 20010

A clinical study for patients using Ampicillin

Florida

Lake Mary Pediatrics
Orange City Florida 32763

A Double-Blind, Randomized, Placebo Controlled Study of CM-AT for the Treatment of Autism in Children 3-8 Years Old.

APG Research
Orlando Florida 32803

A Double-Blind, Randomized, Placebo Controlled Study of CM-AT for the Treatment of Autism in Children 3-8 Years Old.

View More ▼

Bradenton Florida 34201

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Fort Lauderdale Florida 33328

A Phase 2 clinical study for patients with Autism Spectrum Disorders

Fort Lauderdale Florida 33328

A Phase 2 clinical study for patients with Autism Spectrum Disorders

Fort Lauderdale Florida 33314

A Phase 2 clinical study for patients with Autism Spectrum Disorders

Gainesville Florida 32607

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism